• Explore /
  • Poster
  • / Prevalence of <em>EGFR</em> mutations in patients with resected stage I-III non-squamous NSCLC: Results from the EARLY-EGFR study.

Prevalence of EGFR mutations in patients with resected stage I-III non-squamous NSCLC: Results from the EARLY-EGFR study.

Abstract Poster

Authors

null

Ross A. Soo

National University Cancer Institute, National University Hospital, Singapore, Singapore

Ross A. Soo , Thanyanan Reungwetwattana , Herman Andres Perroud , Ullas Batra , Saadettin Kilickap , Luis Fernando Tejado Gallegos , Natalia Donner , Mohamed Alsayed , Reto Huggenberger , Tu Van Dao

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers

Track

Lung Cancer

Sub Track

Biologic Correlates

Clinical Trial Registration Number

NCT04742192

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 8531)

DOI

10.1200/JCO.2023.41.16_suppl.8531

Abstract #

8531

Poster Bd #

158

Abstract Disclosures

Similar Posters

First Author: Benjamin J. Solomon

First Author: Jarushka Naidoo

First Author: Ibiayi Dagogo-Jack

First Author: Nathan A. Pennell